Surya Pharmaceuticals Ltd. - Research Center
SURYAPHARM Group (Z) BSE data
Add to watchlist
| Results |
Half yearly
|
| Statement | |
| More |
Half yearly results in brief
(Rs crore)
| Sep ' 13 | Sep ' 12 | Mar ' 12 | Sep ' 11 | Mar ' 11 | |
|---|---|---|---|---|---|
| Sales | 10.32 | 46.50 | 762.99 | 882.53 | 844.91 |
| Operating profit | -6.24 | -41.43 | 21.84 | 151.71 | 134.50 |
| Interest | 131.08 | 107.08 | 97.76 | 83.58 | 58.18 |
| Gross profit | -137.33 | -147.54 | -71.06 | 68.13 | 81.17 |
| EPS (Rs) | -8.32 | -8.18 | -4.39 | 2.54 | 2.90 |
Half yearly
results in details
| Sep ' 13 | Sep ' 12 | Mar ' 12 | Sep ' 11 | Mar ' 11 | |
|---|---|---|---|---|---|
| Other income | - | 0.97 | 4.85 | - | 4.84 |
| Stock adjustment | 12.96 | -16.87 | -43.77 | -116.76 | -140.58 |
| Raw material | 0.19 | 82.29 | 686.26 | 784.57 | 792.78 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 0.84 | 6.52 | 21.77 | 21.69 | 23.34 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 2.57 | 16.00 | 76.88 | 41.32 | 34.86 |
| Provisions made | - | - | - | - | - |
| Depreciation | 31.34 | 18.27 | 17.99 | 16.62 | 11.47 |
| Taxation | - | - | - | - | 13.89 |
| Net profit / loss | -168.66 | -165.81 | -89.05 | 51.51 | 55.81 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 20.28 | 20.28 | 20.28 | 20.28 | 19.28 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | 1597.14 | 1597.14 | 1254.89 | 1254.89 | 1254.89 |
| Agg.of non promotoholding (%) | 78.77 | 78.77 | 61.89 | 61.89 | 65.10 |
| OPM (%) | -60.48 | -89.11 | 2.86 | 17.19 | 15.92 |
| GPM (%) | - | -310.84 | -9.26 | - | 9.55 |
| NPM (%) | - | -349.33 | -11.60 | - | 6.57 |
© 2025 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis